B S Dwarakanath Selected Research

Deoxyglucose (2 Deoxy D glucose)

1/2013	Protective effect on normal brain tissue during a combinational therapy of 2-deoxy-d-glucose and hypofractionated irradiation in malignant gliomas.
9/2009	Differential responses of tumors and normal brain to the combined treatment of 2-DG and radiation in glioablastoma.
9/2009	Protection of normal cells and tissues during radio- and chemosensitization of tumors by 2-deoxy-D-glucose.
9/2009	Enhancement of radiation and chemotherapeutic drug responses by 2-deoxy-D-glucose in animal tumors.
9/2009	Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects.
9/2009	Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro.
9/2006	Differential mechanisms of radiosensitization by 2-deoxy-D-glucose in the monolayers and multicellular spheroids of a human glioma cell line.
4/2006	Enhancement of radionuclide induced cytotoxicity by 2-deoxy-D-glucose in human tumor cell lines.
8/2005	Glycolytic inhibitor, 2-deoxy-D-glucose, does not enhance radiation-induced apoptosis in mouse thymocytes and splenocytes in vitro.
1/2005	The glycolytic inhibitor 2-deoxy-D-glucose enhances the efficacy of etoposide in ehrlich ascites tumor-bearing mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

B S Dwarakanath Research Topics

Disease

22	Neoplasms (Cancer) 01/2021 - 05/2002
15	Glioma (Gliomas) 01/2013 - 05/2002
5	Necrosis 05/2015 - 01/2003
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2005 - 05/2002
2	Carcinogenesis 01/2021 - 09/2016
2	Inflammation (Inflammations) 09/2016 - 08/2016
2	Neoplasm Metastasis (Metastasis) 09/2016 - 12/2006
2	Glioblastoma (Glioblastoma Multiforme) 01/2013 - 12/2002
2	Ehrlich Tumor Carcinoma 01/2005 - 12/2004
2	Breast Neoplasms (Breast Cancer) 11/2003 - 12/2002
1	Visceral Leishmaniasis (Kala Azar) 12/2012
1	Body Weight (Weight, Body) 09/2009
1	Hypoxia (Hypoxemia) 02/2009
1	Infections 08/2007
1	Malaria 08/2007
1	Parasitemia 08/2007
1	Ascites 01/2005
1	Leukemia 07/2004

Drug/Important Bio-Agent (IBA)

11	Deoxyglucose (2 Deoxy D glucose)IBA 01/2013 - 12/2004
7	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 08/2005
4	Adenosine Triphosphate (ATP)IBA 09/2009 - 08/2005
4	Pharmaceutical PreparationsIBA 09/2009 - 09/2004
4	DNA (Deoxyribonucleic Acid)IBA 08/2005 - 12/2004
4	LigandsIBA 07/2005 - 08/2003
3	Biological ProductsIBA 08/2016 - 12/2002
3	Proteins (Proteins, Gene)FDA Link 01/2014 - 07/2008
3	Etoposide (VP 16)FDA LinkGeneric 01/2005 - 07/2004
2	CytokinesIBA 09/2016 - 08/2016
2	AntioxidantsIBA 09/2016 - 02/2009
2	Radioisotopes (Radionuclides)IBA 04/2006 - 12/2002
2	Cyclin B1IBA 07/2005 - 12/2003
2	Topoisomerase InhibitorsIBA 01/2005 - 07/2004
2	6-Aminonicotinamide (6 Aminonicotinamide)IBA 12/2004 - 12/2003
2	PoisonsIBA 09/2004 - 07/2004
2	trioctyl phosphine oxide (TOPO)IBA 09/2004 - 07/2004
2	CamptothecinIBA 09/2004 - 07/2004
2	Dihydrotachysterol (AT 10)IBA 11/2003 - 05/2002
1	Interleukin-6 (Interleukin 6)IBA 09/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2016
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2016
1	Cyclic AMP (AMP, Cyclic)IBA 08/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2016
1	Arachidonic Acid (Vitamin F)IBA 08/2016
1	Carbon MonoxideIBA 08/2016
1	EnzymesIBA 08/2016
1	Hormones (Hormone)IBA 08/2016
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 08/2016
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 05/2015
1	CalreticulinIBA 01/2014
1	Acetates (Acetic Acid Esters)FDA Link 01/2014
1	Histones (Histone)IBA 01/2014
1	VaccinesIBA 12/2012
1	Nucleic AcidsIBA 08/2010
1	Biomarkers (Surrogate Marker)IBA 08/2010
1	LipidsIBA 08/2010
1	SugarsIBA 08/2010
1	Tumor Biomarkers (Tumor Markers)IBA 08/2010
1	Oxygen (Dioxygen)IBA 02/2009
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 08/2007
1	AntigensIBA 08/2007
1	CalciumIBA 08/2007
1	Chloroquine (Aralen)FDA LinkGeneric 08/2007
1	Nifedipine (Adalat)FDA LinkGeneric 08/2007
1	Verapamil (Calan)FDA LinkGeneric 08/2007
1	FITC-annexin A5IBA 03/2006
1	CyclinsIBA 07/2005
1	Cytotoxins (Cytolysins)IBA 01/2005
1	Therapeutic UsesIBA 01/2005
1	Bisbenzimidazole (Hoechst 33258)IBA 12/2004
1	Radiation-Sensitizing AgentsIBA 12/2004
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 08/2003
1	Photosensitizing Agents (Photosensitizers)IBA 01/2003
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2003
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2003
1	ErbB Receptors (EGF Receptor)IBA 12/2002
1	Immunoconjugates (Immunoconjugate)IBA 12/2002
1	RadiopharmaceuticalsIBA 12/2002
1	Acetic Acid (Vinegar)FDA LinkGeneric 12/2002
1	AntibodiesIBA 12/2002
1	diethylenetriamineIBA 12/2002
1	Cysteine (L-Cysteine)FDA Link 12/2002
1	6- (4- isothiocyanatobenzyl)- diethylenetriamine pentaacetic acidIBA 12/2002
1	PENTAIBA 12/2002
1	Silica GelIBA 12/2002
1	Pentetic Acid (DTPA)FDA LinkGeneric 12/2002
1	Epidermal Growth Factor (EGF)IBA 12/2002
1	methyl 4-mercaptobutyrimidateIBA 12/2002
1	Monoclonal AntibodiesIBA 12/2002

Therapy/Procedure

10	Therapeutics 01/2021 - 03/2006
10	Radiotherapy 01/2021 - 05/2002
2	Drug Therapy (Chemotherapy) 01/2021 - 09/2009
1	Immunotherapy 01/2021
1	Molecular Targeted Therapy 01/2021
1	Photochemotherapy (Photodynamic Therapy) 01/2003